Garivulimab
Product Specifications
CAS Number
2342597-81-1
Target
PD-1/PD-L1, Apoptosis
Related Pathways
Apoptosis, Cell Cycle/Checkpoint, Immunology/Inflammation
Bioactivity
Garivulimab (BGB-A333) is a humanized IgG1-variant monoclonal antibody that specifically targets and binds to PD-L1, thereby selectively inhibiting the PD-L1/PD-1 interaction, which confers its antitumor activity [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
